Tianshui Zhongxing Bio-technology Co

Tianshui Zhongxing Bio-technology Co ROE

The Return on Equity (ROE) of Tianshui Zhongxing Bio-technology Co (002772.SZ) as of Nov 5, 2026 is 9.50 %. In the previous year, Return on Equity (ROE) was 3.86 % — a change of 146.15% (higher).

ROE

9.50 %

YoY

146.15%

Last updated:

In 2025, Tianshui Zhongxing Bio-technology Co's return on equity (ROE) was 9.50 %, a 146.15% increase from the 3.86 % ROE in the previous year.

The Tianshui Zhongxing Bio-technology Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
4.26 CNY
Jan 1, 2019
2.63 CNY
Jan 1, 2020
6.92 CNY
Jan 1, 2021
1.69 CNY
Jan 1, 2022
4.68 CNY
Jan 1, 2023
4.65 CNY
Jan 1, 2024
3.86 CNY
Jan 1, 2025
9.50 CNY
The Tianshui Zhongxing Bio-technology Co ROE history
YEARROEYoY
9.50 %+146.15%
3.86 %-16.98%
4.65 %-0.72%
4.68 %+176.75%
1.69 %-75.56%
6.92 %+163.12%
2.63 %-38.16%
4.26 %-21.49%
5.42 %-21.93%
6.94 %-37.40%
11.09 %-39.51%
18.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tianshui Zhongxing Bio-technology Co Stock analysis

What does Tianshui Zhongxing Bio-technology Co do? Tianshui Zhongxing Bio-Technology Co., Ltd. generates revenue through the research, development, and manufacturing of edible and medical mushrooms. The company sells enoki mushroom, king oyster mushroom, and beech mushroom as its primary edible mushroom products. Through its subsidiaries, it also produces and sells medicinal mushroom, auxiliary materials, and agricultural by-products. The firm focuses on microbial technology, biological engineering, and new agricultural technologies for application and promotion. Its customer segments include consumers seeking edible and medicinal mushroom products, as well as businesses requiring agricultural technology solutions. The company's product portfolio includes edible mushrooms like enoki, king oyster, and beech varieties, alongside medicinal mushrooms and auxiliary materials. Subsidiaries handle production and distribution of these items, leveraging microbial and biological engineering technologies. The business targets both retail consumers and B2B clients in the agricultural and health sectors. Revenue streams are derived from direct sales of mushroom products and technology applications. Tianshui Zhongxing's operations are centered around edible and medical mushroom production, with subsidiaries expanding into agricultural by-products and technology services. The firm's revenue comes from selling enoki, king oyster, and beech mushrooms, medicinal mushrooms, and auxiliary materials. It serves markets requiring mushroom-based health products and agricultural technology innovations, with no mention of external partnerships or additional revenue sources. Tianshui Zhongxing Bio-technology Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Tianshui Zhongxing Bio-technology Co's Return on Equity (ROE)

Tianshui Zhongxing Bio-technology Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Tianshui Zhongxing Bio-technology Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Tianshui Zhongxing Bio-technology Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Tianshui Zhongxing Bio-technology Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Tianshui Zhongxing Bio-technology Co stock

Return on Equity (ROE) of Tianshui Zhongxing Bio-technology Co is 9.50 % in 2025.

Return on Equity (ROE) of Tianshui Zhongxing Bio-technology Co changed from 3.86 % to 9.50 %, representing a 146.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Tianshui Zhongxing Bio-technology Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Tianshui Zhongxing Bio-technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Tianshui Zhongxing Bio-technology Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Tianshui Zhongxing Bio-technology Co